29 Healthcare Stocks Moving In Friday's After-Market Session

Gainers

• ADMA Biologics, Inc. ADMA shares surged 13.2% to $3.94 during Friday's after-market session. The market value of their outstanding shares is at $210.5 million. The most recent rating by Jefferies, on June 04, is at Buy, with a price target of $8.00.
• Gemphire Therapeutics, Inc. GEMP shares moved upwards by 8.6% to $0.67. The market value of their outstanding shares is at $9.6 million.
• Zynerba Pharmaceuticals, Inc. ZYNE stock surged 6.8% to $10.85. The market cap seems to be at $215.8 million.
• Obalon Therapeutics, Inc. OBLN shares rose 5.5% to $3.42. The market value of their outstanding shares is at $17.2 million.
• Acorda Therapeutics, Inc. ACOR stock increased by 5.2% to $3.25. The market cap stands at $292.1 million. The most recent rating by Wedbush, on August 02, is at Neutral, with a price target of $7.00.
• Proteostasis Therapeutics, Inc. PTI shares rose 5.0% to $0.85. The market cap stands at $42.7 million.
• TG Therapeutics, Inc. TGTX stock moved upwards by 4.9% to $7.43. The market cap stands at $665.8 million.
• Leap Therapeutics, Inc. LPTX shares rose 4.4% to $2.39. The market cap stands at $51.6 million.
• Precipio, Inc. PRPO shares rose 4.2% to $2.98. The market cap stands at $17.2 million.
• Global Blood Therapeutics, Inc. GBT shares surged 4.0% to $54.45. The market value of their outstanding shares is at $3.2 billion. The most recent rating by Goldman Sachs, on May 29, is at Neutral, with a price target of $75.00.
• TherapeuticsMD, Inc. TXMD shares increased by 4.0% to $2.10. The market cap stands at $511.3 million.
• Abiomed, Inc. ABMD stock increased by 3.9% to $208.50. The market cap stands at $9.2 billion. The most recent rating by Morgan Stanley, on August 02, is at Equal-Weight, with a price target of $215.00.
• Provention Bio, Inc. PRVB stock increased by 3.3% to $11.00. The market cap stands at $375.4 million. The most recent rating by Chardan Capital, on June 10, is at Buy, with a price target of $20.00.
• Sundial Growers, Inc. SNDL shares rose 2.9% to $10.75. The market cap stands at $702.2 million.
• Kala Pharmaceuticals, Inc. KALA stock rose 2.8% to $5.96. The market cap stands at $201.6 million.
• Aclaris Therapeutics, Inc. ACRS stock increased by 2.7% to $1.14. The market cap seems to be at $49.9 million. According to the most recent rating by SVB Leerink, on June 27, the current rating is at Market Perform.
• Corbus Pharmaceuticals, Inc. CRBP stock increased by 2.6% to $5.80. The market value of their outstanding shares is at $385.4 million.
• Histogenics, Inc. HSGX stock moved upwards by 2.6% to $0.20. The market value of their outstanding shares is at $17.3 million.
• Lexicon Pharmaceuticals, Inc. LXRX shares moved upwards by 2.5% to $1.23. The market value of their outstanding shares is at $139.2 million. The most recent rating by Citigroup, on July 30, is at Buy, with a price target of $3.00.
• Intec Pharma, Inc. NTEC shares increased by 2.1% to $0.52. The market cap stands at $15.5 million.
• Neurocrine Biosciences, Inc. NBIX shares increased by 2.1% to $96.00. The market cap seems to be at $8.7 billion. The most recent rating by Piper Jaffray, on July 30, is at Overweight, with a price target of $111.00.
• Moderna, Inc. MRNA shares surged 2.0% to $12.99. The market cap seems to be at $4.2 billion.

Losers

• GlycoMimetics, Inc. GLYC shares plummeted 39.8% to $5.50 during Friday's after-market session. The market cap stands at $399.4 million.
• Plus Therapeutics, Inc. PSTV shares declined 12.9% to $0.17. The market value of their outstanding shares is at $4.4 million.
• Conatus Pharmaceuticals, Inc. CNAT shares fell 6.0% to $0.31. The market value of their outstanding shares is at $10.2 million.
• Viveve Medical, Inc. VIVE shares plummeted 4.9% to $0.15. The market cap seems to be at $7.3 million. According to the most recent rating by Ladenburg Thalmann, on July 24, the current rating is at Neutral.
• Novavax, Inc. NVAX shares declined 2.5% to $4.23. The market value of their outstanding shares is at $106.5 million.
• CannTrust Holdings, Inc. CTST stock plummeted 2.2% to $2.22. The market value of their outstanding shares is at $307.0 million. According to the most recent rating by Roth Capital, on July 09, the current rating is at Neutral.
• Innovate, Inc. INNT shares decreased by 2.0% to $0.92. The market cap seems to be at $35.7 million.